(arsenic trioxide)
Trisenox 12 MG in 6 ML Injection

Dosage & administration

Newly-diagnosed low-risk APL:

Relapsed or refractory APL:

biomarker testing

Trisenox clinical details

Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.

drug label

Trisenox prescribing information

prior authorization

Trisenox prior authorization resources

Most recent Trisenox prior authorization forms

View By Payer
Updated: May 31, 2023Cigna - Trisenox Prior Authorization Form
Learn More

Benefits investigation

Tevacore Enrollment Form
Learn More

financial assistance

Trisenox financial assistance options

Co-pay savings program

commercial only
Learn More

Foundation programs

under insured
no insurance
goverment insurance

TevaCares Patient Assistance Program Application

Tevacore Enrollment Form
Learn More

patient education

Trisenox patient education

Getting started on Trisenox

To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

Patient toolkit

Learn More

Other resources

Learn More

people also ask

Trisenox FAQs

How is the dosage of Trisenox?Trisenox is available in 1 dosages, including 2 mg/ml Injection 6 ml
What does Trisenox treat?Trisenox treats Acute Promyelocytic Leukemia
How Is Trisenox Administered?Trisenox is administered as a Injectable
FAQ Data Source